Kingdon Capital Exits Praxis Precision Medicines Stake

TL;DR

**Kingdon Capital just dumped all its Praxis Precision Medicines shares.**

AI Summary

Kingdon Capital Management, L.L.C. filed an amended SC 13G/A on February 6, 2024, indicating a significant change in their beneficial ownership of Praxis Precision Medicines, Inc. common stock as of December 31, 2023. The filing shows Kingdon Capital Management now holds 0 shares with sole voting power, a decrease from their previous holdings. This matters to investors because it signals a complete divestment by a notable institutional investor, which could be interpreted as a lack of confidence in the company's future prospects.

Why It Matters

This filing reveals a major institutional investor, Kingdon Capital Management, has completely sold off its stake in Praxis Precision Medicines, which could signal a bearish outlook for the stock.

Risk Assessment

Risk Level: medium — The complete divestment by an institutional investor like Kingdon Capital Management could indicate underlying concerns about Praxis Precision Medicines, increasing investment risk.

Analyst Insight

A smart investor would investigate the reasons behind Kingdon Capital Management's complete divestment and consider if this signals broader concerns about Praxis Precision Medicines' fundamentals or future prospects before making investment decisions.

Key Numbers

• 0 — Sole Voting Power Shares (Kingdon Capital Management, L.L.C. now holds zero shares with sole voting power in Praxis Precision Medicines, Inc.)
• 74006W207 — CUSIP Number (Identifies the Common Stock, par value $0.0001 per share, of Praxis Precision Medicines, Inc.)

Key Players & Entities

• Kingdon Capital Management, L.L.C. (company) — the reporting person who filed the SC 13G/A
• Praxis Precision Medicines, Inc. (company) — the subject company whose stock is being reported
• Delaware (place) — state of organization for Kingdon Capital Management, L.L.C.
• 0 (number) — number of shares with sole voting power beneficially owned by Kingdon Capital Management, L.L.C.

Forward-Looking Statements

• Praxis Precision Medicines, Inc. stock price may experience downward pressure. (Praxis Precision Medicines, Inc.) — medium confidence, target: Q1 2024

FAQ

Key Financial Figures

• $0.0001 — me of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securiti

Filing Documents

• d10943124_13g-a.htm (SC 13G/A) — 143KB
• 0000919574-24-000689.txt ( ) — 145KB

From the Filing

SC 13G/A 1 d10943124_13g-a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Praxis Precision Medicines, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 74006W207 (CUSIP Number) December 31 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [_] Rule 13d-1(b) [X] Rule 13d-1(c) [_] Rule 13d-1(d) __________ * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No 74006W207 1. NAME OF REPORTING PERSONS Kingdon Capital Management, L.L.C. 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [_] (b) [X] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 346,665 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 346,665 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 346,665 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [_] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 2.90% 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IA CUSIP No 74006W207 1. NAME OF REPORTING PERSONS M. Kingdon Offshore Master Fund L.P. 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [_] (b) [X] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Cayman Islands NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 294,665 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 294,665 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 294,665 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [_] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 2.46% 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) PN CUSIP No 74006W207 1. NAME OF REPORTING PERSONS Kingdon GP, LLC 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [_] (b) [X] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 294,665 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 294,665 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 294,665 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [_] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 2.46% 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) OO CUSIP No 74006W207 1. NAME OF REPORTING PERSONS Mark Kingdon 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [_] (b) [X] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION United States of America NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 346,665 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 346,665 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 346,665 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [_] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 2.90% 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN, HC CUSIP No 74006W207 Item 1. (a). Name of Issuer: Praxis Precision Medicines, Inc. (b). Address of Issuer's Principal Executive Offices: 99 High Street, 30th Floor Boston, MA 02110 United States of America Item 2. (a). Name of Person Filing: Kingdon Capital Management, L.L.C. M. Kingdon Offshore Master Fund L.P. Kingdon GP, LLC Mark Kingdon (b). Address of Principal Business Office, or if None, Residence: Kingdon Capital Management, L.L.C. 152 West 57th Street, 50th Floor New York, New York 10019 United States of America M. Kingdon Offshore Master Fund L.P. c/o Kingdon Capital Management, L.L.C. 152 West 57th Street, 50th Floor New York, New York 10019 United States of America Kingdon GP, LLC c/o Kingdon Capital Mana

View Full Filing

View this SC 13G/A filing on SEC EDGAR